Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000077

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jun 7, 2017
Accepted (ET)
Jun 13, 2017 · 1:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJun 7, 2017P1,000$0.06A21,111,349D
Common StockJun 7, 2017P1,000$0.0599A21,112,349D
Common StockJun 7, 2017P1,000$0.0599A21,113,349D
Common StockJun 7, 2017P1,000$0.0597A21,114,349D
Common StockJun 7, 2017P1,000$0.0599A21,115,349D
Common StockJun 7, 2017P1,000$0.0597A21,116,349D
Common StockJun 7, 2017P1,000$0.0599A21,117,349D
Common StockJun 7, 2017P1,000$0.0599A21,118,349D
Common StockJun 7, 2017P1,000$0.0599A21,119,349D
Common StockJun 7, 2017P1,000$0.0599A21,120,349D
Common StockJun 7, 2017P1,000$0.0599A21,121,349D
Common StockJun 7, 2017P1,000$0.0599A21,122,349D
Common StockJun 7, 2017P1,000$0.0599A21,123,349D
Common StockJun 7, 2017P4,000$0.0599A21,127,349D
Common StockJun 7, 2017P1,000$0.0599A21,128,349D
Common StockJun 7, 2017P1,000$0.056A21,129,349D
Common StockJun 7, 2017P1,000$0.0597A21,130,349D
Common StockJun 7, 2017P1,000$0.0535A21,131,349D
Common StockJun 7, 2017P1,000$0.0596A21,132,349D
Common StockJun 7, 2017P1,000$0.0547A21,133,349D
Common StockJun 7, 2017P1,000$0.055A21,134,349D
Common StockJun 7, 2017P1,000$0.055A21,135,349D
Common StockJun 7, 2017P1,000$0.055A21,136,349D
Common StockJun 7, 2017P1,000$0.055A21,137,349D
Common StockJun 7, 2017P1,000$0.0595A21,138,349D
Common StockJun 7, 2017P1,000$0.0595A21,139,349D
Common StockJun 7, 2017P1,000$0.0595A21,140,349D
Common StockJun 7, 2017P1,000$0.0595A21,141,349D
Common StockJun 7, 2017P1,000$0.0594A21,142,349D
Common StockJun 8, 2017P1,000$0.0589A21,143,349D

Table II — derivative securities

No Table II lines on this filing.